Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug 20;7(5):e858.
doi: 10.1212/NXI.0000000000000858. Print 2020 Sep.

N2 in the time of COVID-19

Josep Dalmau  1
Affiliations
Editorial

N2 in the time of COVID-19

Josep Dalmau. Neurol Neuroimmunol Neuroinflamm. .
No abstract available

PubMed Disclaimer

Comment on

  • Painful trigeminal neuropathy associated with anti-Plexin D1 antibody.
    Fujii T, Yamasaki R, Miyachi Y, Iinuma K, Hashimoto Y, Isobe N, Matsushita T, Kira JI. Fujii T, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Jun 25;7(5):e819. doi: 10.1212/NXI.0000000000000819. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32587101 Free PMC article.
  • CSF chitinase 3-like-1 association with disability of primary progressive MS.
    Pérez-Miralles F, Prefasi D, García-Merino A, Gascón-Giménez F, Medrano N, Castillo-Villalba J, Cubas L, Alcalá C, Gil-Perotín S, Gómez-Ballesteros R, Maurino J, Álvarez-García E, Casanova B. Pérez-Miralles F, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Jul 1;7(5):e815. doi: 10.1212/NXI.0000000000000815. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32611760 Free PMC article.
  • COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center.
    Parrotta E, Kister I, Charvet L, Sammarco C, Saha V, Charlson RE, Howard J, Gutman JM, Gottesman M, Abou-Fayssal N, Wolintz R, Keilson M, Fernandez-Carbonell C, Krupp LB, Zhovtis Ryerson L. Parrotta E, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Jul 9;7(5):e835. doi: 10.1212/NXI.0000000000000835. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32646885 Free PMC article.
  • Treatment and outcome of aquaporin-4 antibody-positive NMOSD: A multinational pediatric study.
    Paolilo RB, Hacohen Y, Yazbeck E, Armangue T, Bruijstens A, Lechner C, Apostolos-Pereira SL, Martynenko Y, Breu M, de Medeiros Rimkus C, Wassmer E, Baumann M, Papetti L, Capobianco M, Kornek B, Rostásy K, da Paz JA, Ciccarelli O, Lim M, Saiz A, Neuteboom R, Marignier R, Hemingway C, Sato DK, Deiva K. Paolilo RB, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Jul 30;7(5):e837. doi: 10.1212/NXI.0000000000000837. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32732259 Free PMC article.

References

    1. Parotta E, Kister I, Charvet L, et al. . COVID-19 outcomes in MS: observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center. Neurol Neuroimmunol Neuroinflamm 2020;7:e835 doi: 10.1212/NXI.0000000000000835. - DOI - PMC - PubMed
    1. Barbosa Paolilo R, Hacohen Y, Yazbeck E, et al. . Treatment and outcome of aquaporin-4 antibody–positive NMOSD: a multinational pediatric study. Neurol Neuroimmunol Neuroinflamm 2020;7:e837. doi: 10.1212/NXI.0000000000000837. - DOI - PMC - PubMed
    1. Fujii T, Yamasaki R, Miyachi Y, et al. . Painful trigeminal neuropathy associated with anti-Plexin D1 antibody. Neurol Neuroimmunol Neuroinflamm 2020;7:e819 doi: 10.1212/NXI.0000000000000819. - DOI - PMC - PubMed
    1. Fujii T, Yamasaki R, Iinuma K, et al. . A novel autoantibody against Plexin D1 in patients with neuropathic pain. Ann Neurol 2018;84:208–224. - PubMed
    1. Pérez-Miralles F, Prefasi D, Garcia-Merino A. CSF chitinase 3-like-1 association with disability of primary progressive MS. Neurol Neuroimmunol Neuroinflamm 2020;7:e815 doi: 10.1212/NXI.0000000000000815. - DOI - PMC - PubMed